{"entity":{"type":"insider","cik":"0001377832","url":"/insider/0001377832","json_url":"/insider/0001377832.json","name":"Strobeck Matthew","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":70,"n_filings":26,"first":"2007-06-14","last":"2026-02-13","span_basis":"filed_date"},"name_variants":[{"name":"Strobeck Matthew","source":"filing","n_filings":26,"first_seen":"2007-06-14","last_seen":"2026-02-13"}],"transactions":[{"id":6205593,"accession":"0001377832-26-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001377832-26-000003","line_url":"/filing/0001377832-26-000003#line-1","is_derivative":false,"issuer_cik":"0001377832","issuer_name":"QuidelOrtho Corp","issuer_ticker":"QDEL","issuer_name_source":null,"issuer_url":"/issuer/0001377832","owner_cik":"0001377832","owner_name":"Strobeck Matthew","owner_display_name":"Strobeck Matthew","owner_url":"/insider/0001377832","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":23.9586,"price_display":"23.96","price_state":"stated","total_value":239586.0,"total_display":"239,586.00","total_whole":"239,586","shares_owned_after":27775.0,"shares_owned_after_display":"27,775","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-13","filed_date":"2026-02-13","scope":"insider"},{"id":2456499,"accession":"0000905148-24-002950","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905148-24-002950","line_url":"/filing/0000905148-24-002950","is_derivative":false,"issuer_cik":"0001377832","issuer_name":"BIODESIX INC","issuer_ticker":"BDSX","issuer_name_source":null,"issuer_url":"/issuer/0001377832","owner_cik":"0001377832","owner_name":"Strobeck Matthew","owner_display_name":"Strobeck Matthew","owner_url":"/insider/0001377832","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":1.3979,"price_display":"1.40","price_state":"stated","total_value":55916.0,"total_display":"55,916.00","total_whole":"55,916","shares_owned_after":2606879.0,"shares_owned_after_display":"2,606,879","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-11-05","filed_date":"2024-11-06","scope":"insider","n_lines":2},{"id":3268144,"accession":"0001104659-24-006678","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-006678","line_url":"/filing/0001104659-24-006678#line-1","is_derivative":false,"issuer_cik":"0000727207","issuer_name":"Accelerate Diagnostics, Inc","issuer_ticker":"AXDX","issuer_name_source":null,"issuer_url":"/issuer/0000727207","owner_cik":"0001377832","owner_name":"Strobeck Matthew","owner_display_name":"Strobeck Matthew","owner_url":"/insider/0001377832","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":120682.0,"shares_owned_after_display":"120,682","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-23","filed_date":"2024-01-25","scope":"insider"},{"id":9223847,"accession":"0001104659-24-025392","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-24-025392","line_url":"/filing/0001104659-24-025392#line-5","is_derivative":false,"issuer_cik":"0001377832","issuer_name":"ELUTIA INC.","issuer_ticker":"ELUT","issuer_name_source":null,"issuer_url":"/issuer/0001377832","owner_cik":null,"owner_name":"Birchview Capital, LP; Birchview Fund LLC; Strobeck Matthew","owner_display_name":"Birchview Capital, LP","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.587,"price_display":"1.59","price_state":"stated","total_value":15870.0,"total_display":"15,870.00","total_whole":"15,870","shares_owned_after":1655184.0,"shares_owned_after_display":"1,655,184","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-27","filed_date":"2024-02-20","scope":"insider"},{"id":7891196,"accession":"0001104659-23-037129","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-23-037129","line_url":"/filing/0001104659-23-037129#line-5","is_derivative":false,"issuer_cik":"0001377832","issuer_name":"AZIYO BIOLOGICS, INC.","issuer_ticker":"AZYO","issuer_name_source":null,"issuer_url":"/issuer/0001377832","owner_cik":null,"owner_name":"Birchview Fund LLC; Birchview Capital, LP; Strobeck Matthew","owner_display_name":"Birchview Fund LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.587,"price_display":"1.59","price_state":"stated","total_value":15870.0,"total_display":"15,870.00","total_whole":"15,870","shares_owned_after":1655184.0,"shares_owned_after_display":"1,655,184","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-27","filed_date":"2023-03-27","scope":"insider"},{"id":9223849,"accession":"0001104659-24-025392","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-24-025392","line_url":"/filing/0001104659-24-025392","is_derivative":false,"issuer_cik":"0001377832","issuer_name":"ELUTIA INC.","issuer_ticker":"ELUT","issuer_name_source":null,"issuer_url":"/issuer/0001377832","owner_cik":null,"owner_name":"Birchview Capital, LP; Birchview Fund LLC; Strobeck Matthew","owner_display_name":"Birchview Capital, LP","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":1.3539,"price_display":"1.35","price_state":"stated","total_value":27078.0,"total_display":"27,078.00","total_whole":"27,078","shares_owned_after":1643184.0,"shares_owned_after_display":"1,643,184","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-24","filed_date":"2024-02-20","scope":"insider","n_lines":2},{"id":7891194,"accession":"0001104659-23-037129","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-23-037129","line_url":"/filing/0001104659-23-037129","is_derivative":false,"issuer_cik":"0001377832","issuer_name":"AZIYO BIOLOGICS, INC.","issuer_ticker":"AZYO","issuer_name_source":null,"issuer_url":"/issuer/0001377832","owner_cik":null,"owner_name":"Birchview Fund LLC; Birchview Capital, LP; Strobeck Matthew","owner_display_name":"Birchview Fund LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":1.3539,"price_display":"1.35","price_state":"stated","total_value":27078.0,"total_display":"27,078.00","total_whole":"27,078","shares_owned_after":1643184.0,"shares_owned_after_display":"1,643,184","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-24","filed_date":"2023-03-27","scope":"insider","n_lines":2},{"id":9223848,"accession":"0001104659-24-025392","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-025392","line_url":"/filing/0001104659-24-025392","is_derivative":false,"issuer_cik":"0001377832","issuer_name":"ELUTIA INC.","issuer_ticker":"ELUT","issuer_name_source":null,"issuer_url":"/issuer/0001377832","owner_cik":null,"owner_name":"Birchview Capital, LP; Birchview Fund LLC; Strobeck Matthew","owner_display_name":"Birchview Capital, LP","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":110000.0,"shares_display":"110,000","price_per_share":1.491,"price_display":"1.49","price_state":"stated","total_value":164010.0,"total_display":"164,010.00","total_whole":"164,010","shares_owned_after":1615184.0,"shares_owned_after_display":"1,615,184","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-23","filed_date":"2024-02-20","scope":"insider","n_lines":2},{"id":7891188,"accession":"0001104659-23-037129","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-037129","line_url":"/filing/0001104659-23-037129","is_derivative":false,"issuer_cik":"0001377832","issuer_name":"AZIYO BIOLOGICS, INC.","issuer_ticker":"AZYO","issuer_name_source":null,"issuer_url":"/issuer/0001377832","owner_cik":null,"owner_name":"Birchview Fund LLC; Birchview Capital, LP; Strobeck Matthew","owner_display_name":"Birchview Fund LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":110000.0,"shares_display":"110,000","price_per_share":1.491,"price_display":"1.49","price_state":"stated","total_value":164010.0,"total_display":"164,010.00","total_whole":"164,010","shares_owned_after":1615184.0,"shares_owned_after_display":"1,615,184","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-23","filed_date":"2023-03-27","scope":"insider","n_lines":2},{"id":8118487,"accession":"0001104659-23-019991","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001104659-23-019991","line_url":"/filing/0001104659-23-019991","is_derivative":false,"issuer_cik":"0001377832","issuer_name":"AZIYO BIOLOGICS, INC.","issuer_ticker":"AZYO","issuer_name_source":null,"issuer_url":"/issuer/0001377832","owner_cik":null,"owner_name":"Birchview Fund LLC; Strobeck Matthew; Birchview Capital, LP","owner_display_name":"Birchview Fund LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13061.0,"shares_display":"13,061","price_per_share":3.791266204731644,"price_display":"3.79","price_state":"stated","total_value":49517.7279,"total_display":"49,517.73","total_whole":"49,518","shares_owned_after":1511184.0,"shares_owned_after_display":"1,511,184","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-08","filed_date":"2023-02-13","scope":"insider","n_lines":2},{"id":8118480,"accession":"0001104659-23-019991","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-23-019991","line_url":"/filing/0001104659-23-019991","is_derivative":false,"issuer_cik":"0001377832","issuer_name":"AZIYO BIOLOGICS, INC.","issuer_ticker":"AZYO","issuer_name_source":null,"issuer_url":"/issuer/0001377832","owner_cik":null,"owner_name":"Birchview Fund LLC; Strobeck Matthew; Birchview Capital, LP","owner_display_name":"Birchview Fund LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":44000.0,"shares_display":"44,000","price_per_share":3.58,"price_display":"3.58","price_state":"stated","total_value":157520.0,"total_display":"157,520.00","total_whole":"157,520","shares_owned_after":1502123.0,"shares_owned_after_display":"1,502,123","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-07","filed_date":"2023-02-13","scope":"insider","n_lines":2},{"id":8118475,"accession":"0001104659-23-019991","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-019991","line_url":"/filing/0001104659-23-019991#line-2","is_derivative":false,"issuer_cik":"0001377832","issuer_name":"AZIYO BIOLOGICS, INC.","issuer_ticker":"AZYO","issuer_name_source":null,"issuer_url":"/issuer/0001377832","owner_cik":null,"owner_name":"Birchview Fund LLC; Strobeck Matthew; Birchview Capital, LP","owner_display_name":"Birchview Fund LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":4.75,"price_display":"4.75","price_state":"stated","total_value":190000.0,"total_display":"190,000.00","total_whole":"190,000","shares_owned_after":1458123.0,"shares_owned_after_display":"1,458,123","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-01","filed_date":"2023-02-13","scope":"insider"},{"id":6563218,"accession":"0001140361-22-042597","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001140361-22-042597","line_url":"/filing/0001140361-22-042597","is_derivative":false,"issuer_cik":"0001377832","issuer_name":"BIODESIX INC","issuer_ticker":"BDSX","issuer_name_source":null,"issuer_url":"/issuer/0001377832","owner_cik":"0001377832","owner_name":"Strobeck Matthew","owner_display_name":"Strobeck Matthew","owner_url":"/insider/0001377832","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2669562.0,"shares_display":"2,669,562","price_per_share":1.15,"price_display":"1.15","price_state":"stated","total_value":3069996.3,"total_display":"3,069,996.30","total_whole":"3,069,996","shares_owned_after":2135076.0,"shares_owned_after_display":"2,135,076","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-21","filed_date":"2022-11-21","scope":"insider","n_lines":6},{"id":8118471,"accession":"0001104659-23-019991","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-019991","line_url":"/filing/0001104659-23-019991#line-1","is_derivative":false,"issuer_cik":"0001377832","issuer_name":"AZIYO BIOLOGICS, INC.","issuer_ticker":"AZYO","issuer_name_source":null,"issuer_url":"/issuer/0001377832","owner_cik":null,"owner_name":"Birchview Fund LLC; Strobeck Matthew; Birchview Capital, LP","owner_display_name":"Birchview Fund LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":5.9604,"price_display":"5.96","price_state":"stated","total_value":1192.08,"total_display":"1,192.08","total_whole":"1,192","shares_owned_after":1418123.0,"shares_owned_after_display":"1,418,123","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-11","filed_date":"2023-02-13","scope":"insider"},{"id":6355688,"accession":"0001567619-22-008353","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-22-008353","line_url":"/filing/0001567619-22-008353","is_derivative":false,"issuer_cik":"0001377832","issuer_name":"BIODESIX INC","issuer_ticker":"BDSX","issuer_name_source":null,"issuer_url":"/issuer/0001377832","owner_cik":"0001377832","owner_name":"Strobeck Matthew","owner_display_name":"Strobeck Matthew","owner_url":"/insider/0001377832","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1117318.0,"shares_display":"1,117,318","price_per_share":1.79,"price_display":"1.79","price_state":"stated","total_value":1999999.22,"total_display":"1,999,999.22","total_whole":"1,999,999","shares_owned_after":1545586.0,"shares_owned_after_display":"1,545,586","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-07","filed_date":"2022-04-11","scope":"insider","n_lines":2},{"id":6226335,"accession":"0001567619-22-000277","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-22-000277","line_url":"/filing/0001567619-22-000277","is_derivative":false,"issuer_cik":"0001377832","issuer_name":"BIODESIX INC","issuer_ticker":"BDSX","issuer_name_source":null,"issuer_url":"/issuer/0001377832","owner_cik":"0001377832","owner_name":"Strobeck Matthew","owner_display_name":"Strobeck Matthew","owner_url":"/insider/0001377832","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":147800.0,"shares_display":"147,800","price_per_share":4.35,"price_display":"4.35","price_state":"stated","total_value":642930.0,"total_display":"642,930.00","total_whole":"642,930","shares_owned_after":211200.0,"shares_owned_after_display":"211,200","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-30","filed_date":"2022-01-04","scope":"insider","n_lines":2},{"id":3284952,"accession":"0001209191-20-056750","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-20-056750","line_url":"/filing/0001209191-20-056750#line-9","is_derivative":false,"issuer_cik":"0001377832","issuer_name":"BIODESIX INC","issuer_ticker":"BDSX","issuer_name_source":null,"issuer_url":"/issuer/0001377832","owner_cik":"0001377832","owner_name":"Strobeck Matthew","owner_display_name":"Strobeck Matthew","owner_url":"/insider/0001377832","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":83333.0,"shares_display":"83,333","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":1499994.0,"total_display":"1,499,994.00","total_whole":"1,499,994","shares_owned_after":83333.0,"shares_owned_after_display":"83,333","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-10-30","filed_date":"2020-11-03","scope":"insider"},{"id":3018063,"accession":"0001209191-20-049663","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-049663","line_url":"/filing/0001209191-20-049663","is_derivative":false,"issuer_cik":"0000353569","issuer_name":"QUIDEL CORP /DE/","issuer_ticker":"QDEL","issuer_name_source":null,"issuer_url":"/issuer/0000353569","owner_cik":"0001377832","owner_name":"Strobeck Matthew","owner_display_name":"Strobeck Matthew","owner_url":"/insider/0001377832","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400.0,"shares_display":"400","price_per_share":155.634625,"price_display":"155.63","price_state":"stated","total_value":62253.85,"total_display":"62,253.85","total_whole":"62,254","shares_owned_after":38095.0,"shares_owned_after_display":"38,095","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-09-03","filed_date":"2020-09-04","scope":"insider","n_lines":2},{"id":3018051,"accession":"0001209191-20-049663","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-049663","line_url":"/filing/0001209191-20-049663","is_derivative":false,"issuer_cik":"0000353569","issuer_name":"QUIDEL CORP /DE/","issuer_ticker":"QDEL","issuer_name_source":null,"issuer_url":"/issuer/0000353569","owner_cik":"0001377832","owner_name":"Strobeck Matthew","owner_display_name":"Strobeck Matthew","owner_url":"/insider/0001377832","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7300.0,"shares_display":"7,300","price_per_share":166.645301369863,"price_display":"166.65","price_state":"stated","total_value":1216510.7,"total_display":"1,216,510.70","total_whole":"1,216,511","shares_owned_after":37445.0,"shares_owned_after_display":"37,445","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-09-02","filed_date":"2020-09-04","scope":"insider","n_lines":2},{"id":3200562,"accession":"0001628280-20-003862","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-20-003862","line_url":"/filing/0001628280-20-003862#line-3","is_derivative":false,"issuer_cik":"0000727207","issuer_name":"Accelerate Diagnostics, Inc","issuer_ticker":"AXDX","issuer_name_source":null,"issuer_url":"/issuer/0000727207","owner_cik":"0001377832","owner_name":"Strobeck Matthew","owner_display_name":"Strobeck Matthew","owner_url":"/insider/0001377832","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":7.11,"price_display":"7.11","price_state":"stated","total_value":71100.0,"total_display":"71,100.00","total_whole":"71,100","shares_owned_after":148235.0,"shares_owned_after_display":"148,235","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-18","filed_date":"2020-03-20","scope":"insider"},{"id":4413121,"accession":"0001144204-17-001695","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-17-001695","line_url":"/filing/0001144204-17-001695#line-1","is_derivative":false,"issuer_cik":"0000727207","issuer_name":"Accelerate Diagnostics, Inc","issuer_ticker":"AXDX","issuer_name_source":null,"issuer_url":"/issuer/0000727207","owner_cik":"0001377832","owner_name":"Strobeck Matthew","owner_display_name":"Strobeck Matthew","owner_url":"/insider/0001377832","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8000.0,"shares_display":"8,000","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":152000.0,"total_display":"152,000.00","total_whole":"152,000","shares_owned_after":138235.0,"shares_owned_after_display":"138,235","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-01-09","filed_date":"2017-01-10","scope":"insider"},{"id":2255343,"accession":"0001144204-16-080228","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-080228","line_url":"/filing/0001144204-16-080228#line-1","is_derivative":false,"issuer_cik":"0000727207","issuer_name":"Accelerate Diagnostics, Inc","issuer_ticker":"AXDX","issuer_name_source":null,"issuer_url":"/issuer/0000727207","owner_cik":"0001377832","owner_name":"Strobeck Matthew","owner_display_name":"Strobeck Matthew","owner_url":"/insider/0001377832","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":11.52,"price_display":"11.52","price_state":"stated","total_value":230400.0,"total_display":"230,400.00","total_whole":"230,400","shares_owned_after":130235.0,"shares_owned_after_display":"130,235","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-02-09","filed_date":"2016-02-10","scope":"insider"},{"id":8071767,"accession":"0001144204-15-071582","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-071582","line_url":"/filing/0001144204-15-071582#line-1","is_derivative":false,"issuer_cik":"0000727207","issuer_name":"Accelerate Diagnostics, Inc","issuer_ticker":"AXDX","issuer_name_source":null,"issuer_url":"/issuer/0000727207","owner_cik":"0001377832","owner_name":"Strobeck Matthew","owner_display_name":"Strobeck Matthew","owner_url":"/insider/0001377832","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":88235.0,"shares_display":"88,235","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":1499995.0,"total_display":"1,499,995.00","total_whole":"1,499,995","shares_owned_after":110235.0,"shares_owned_after_display":"110,235","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-12-15","filed_date":"2015-12-17","scope":"insider"},{"id":8366708,"accession":"0001179110-15-010186","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-15-010186","line_url":"/filing/0001179110-15-010186","is_derivative":false,"issuer_cik":"0001121702","issuer_name":"METABOLIX, INC.","issuer_ticker":"MBLX","issuer_name_source":null,"issuer_url":"/issuer/0001121702","owner_cik":"0001377832","owner_name":"Strobeck Matthew","owner_display_name":"Strobeck Matthew","owner_url":"/insider/0001377832","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":145670.0,"shares_display":"145,670","price_per_share":3.32,"price_display":"3.32","price_state":"stated","total_value":483624.4,"total_display":"483,624.40","total_whole":"483,624","shares_owned_after":1486136.0,"shares_owned_after_display":"1,486,136","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-19","filed_date":"2015-06-23","scope":"insider","n_lines":2},{"id":8298275,"accession":"0001144204-15-017674","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-017674","line_url":"/filing/0001144204-15-017674#line-1","is_derivative":false,"issuer_cik":"0000727207","issuer_name":"Accelerate Diagnostics, Inc","issuer_ticker":"AXDX","issuer_name_source":null,"issuer_url":"/issuer/0000727207","owner_cik":"0001377832","owner_name":"Strobeck Matthew","owner_display_name":"Strobeck Matthew","owner_url":"/insider/0001377832","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":22.04,"price_display":"22.04","price_state":"stated","total_value":44080.0,"total_display":"44,080.00","total_whole":"44,080","shares_owned_after":22000.0,"shares_owned_after_display":"22,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-03-19","filed_date":"2015-03-23","scope":"insider"},{"id":6694368,"accession":"0001179110-14-013292","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001179110-14-013292","line_url":"/filing/0001179110-14-013292#line-6","is_derivative":false,"issuer_cik":"0001121702","issuer_name":"METABOLIX, INC.","issuer_ticker":"MBLX","issuer_name_source":null,"issuer_url":"/issuer/0001121702","owner_cik":"0001377832","owner_name":"Strobeck Matthew","owner_display_name":"Strobeck Matthew","owner_url":"/insider/0001377832","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3800000.0,"shares_display":"3,800,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":4505000.0,"shares_owned_after_display":"4,505,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-22","filed_date":"2014-08-26","scope":"insider"},{"id":6694367,"accession":"0001179110-14-013292","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179110-14-013292","line_url":"/filing/0001179110-14-013292#line-5","is_derivative":false,"issuer_cik":"0001121702","issuer_name":"METABOLIX, INC.","issuer_ticker":"MBLX","issuer_name_source":null,"issuer_url":"/issuer/0001121702","owner_cik":"0001377832","owner_name":"Strobeck Matthew","owner_display_name":"Strobeck Matthew","owner_url":"/insider/0001377832","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000000.0,"shares_display":"2,000,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":2000000.0,"shares_owned_after_display":"2,000,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-08-22","filed_date":"2014-08-26","scope":"insider"},{"id":6694366,"accession":"0001179110-14-013292","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-14-013292","line_url":"/filing/0001179110-14-013292#line-4","is_derivative":false,"issuer_cik":"0001121702","issuer_name":"METABOLIX, INC.","issuer_ticker":"MBLX","issuer_name_source":null,"issuer_url":"/issuer/0001121702","owner_cik":"0001377832","owner_name":"Strobeck Matthew","owner_display_name":"Strobeck Matthew","owner_url":"/insider/0001377832","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-08-22","filed_date":"2014-08-26","scope":"insider"},{"id":6694364,"accession":"0001179110-14-013292","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-14-013292","line_url":"/filing/0001179110-14-013292#line-3","is_derivative":false,"issuer_cik":"0001121702","issuer_name":"METABOLIX, INC.","issuer_ticker":"MBLX","issuer_name_source":null,"issuer_url":"/issuer/0001121702","owner_cik":"0001377832","owner_name":"Strobeck Matthew","owner_display_name":"Strobeck Matthew","owner_url":"/insider/0001377832","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-08-22","filed_date":"2014-08-26","scope":"insider"},{"id":6694362,"accession":"0001179110-14-013292","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-14-013292","line_url":"/filing/0001179110-14-013292#line-2","is_derivative":false,"issuer_cik":"0001121702","issuer_name":"METABOLIX, INC.","issuer_ticker":"MBLX","issuer_name_source":null,"issuer_url":"/issuer/0001121702","owner_cik":"0001377832","owner_name":"Strobeck Matthew","owner_display_name":"Strobeck Matthew","owner_url":"/insider/0001377832","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-08-22","filed_date":"2014-08-26","scope":"insider"},{"id":6694359,"accession":"0001179110-14-013292","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-14-013292","line_url":"/filing/0001179110-14-013292#line-1","is_derivative":false,"issuer_cik":"0001121702","issuer_name":"METABOLIX, INC.","issuer_ticker":"MBLX","issuer_name_source":null,"issuer_url":"/issuer/0001121702","owner_cik":"0001377832","owner_name":"Strobeck Matthew","owner_display_name":"Strobeck Matthew","owner_url":"/insider/0001377832","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-08-22","filed_date":"2014-08-26","scope":"insider"},{"id":6488018,"accession":"0001144204-14-047200","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-047200","line_url":"/filing/0001144204-14-047200#line-1","is_derivative":false,"issuer_cik":"0000727207","issuer_name":"Accelerate Diagnostics, Inc","issuer_ticker":"AXDX","issuer_name_source":null,"issuer_url":"/issuer/0000727207","owner_cik":"0001377832","owner_name":"Strobeck Matthew","owner_display_name":"Strobeck Matthew","owner_url":"/insider/0001377832","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":16.7,"price_display":"16.70","price_state":"stated","total_value":334000.0,"total_display":"334,000.00","total_whole":"334,000","shares_owned_after":2065560.0,"shares_owned_after_display":"2,065,560","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-08-05","filed_date":"2014-08-06","scope":"insider"},{"id":9236566,"accession":"0001144204-14-047277","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-047277","line_url":"/filing/0001144204-14-047277#line-1","is_derivative":false,"issuer_cik":"0001377832","issuer_name":"Accelerate Diagnostics, Inc","issuer_ticker":"AXDX","issuer_name_source":null,"issuer_url":"/issuer/0001377832","owner_cik":"0001377832","owner_name":"Strobeck Matthew","owner_display_name":"Strobeck Matthew","owner_url":"/insider/0001377832","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":16.7,"price_display":"16.70","price_state":"stated","total_value":334000.0,"total_display":"334,000.00","total_whole":"334,000","shares_owned_after":2065560.0,"shares_owned_after_display":"2,065,560","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-08-04","filed_date":"2014-08-06","scope":"insider"}],"collapsed":true,"next_cursor":"2014-08-04|9236566","ledger_fault":false,"count":{"value":54,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":41,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":54},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001906324","name":"QuidelOrtho Corp","url":"/issuer/0001906324","role":"Director","n_filings":1,"first_seen":"2026-02-13","last_seen":"2026-02-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001439725","name":"BIODESIX INC","url":"/issuer/0001439725","role":"Director","n_filings":5,"first_seen":"2020-11-03","last_seen":"2024-11-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001708527","name":"ELUTIA INC.","url":"/issuer/0001708527","role":"Ten percent owner, Other","n_filings":3,"first_seen":"2023-02-13","last_seen":"2024-02-20"},{"type":"issuer","type_label":"ISSUER","cik":"0000727207","name":"Accelerate Diagnostics, Inc","url":"/issuer/0000727207","role":"Director","n_filings":8,"first_seen":"2014-08-06","last_seen":"2024-01-25"},{"type":"issuer","type_label":"ISSUER","cik":"0000353569","name":"QUIDEL CORP /DE/","url":"/issuer/0000353569","role":"Director","n_filings":1,"first_seen":"2020-09-04","last_seen":"2020-09-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001121702","name":"METABOLIX, INC.","url":"/issuer/0001121702","role":"Director","n_filings":8,"first_seen":"2007-06-14","last_seen":"2015-06-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001377832","retrieved_at":"2026-08-26T19:21:11+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}